Ernst Schlogl
Overview
Explore the profile of Ernst Schlogl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeryczynski G, Thiele J, Gisslinger B, Wolfler A, Schalling M, Gleiss A, et al.
Am J Hematol
. 2017 May;
92(9):885-891.
PMID: 28543356
The 2016 revised WHO criteria for the diagnosis of pre-fibrotic/early primary myelofibrosis (pre-PMF) require at least one of the following four borderline expressed minor clinical criteria: anemia, leukocytosis, elevated lactate...
2.
Burgstaller S, Fridrik M, Hojas S, Kuhr T, Ludwig H, Mayrbaurl B, et al.
Wien Klin Wochenschr
. 2013 Mar;
125(7-8):196-9.
PMID: 23536018
Current literature provides conflicting evidence regarding the efficacy of lenalidomide in patients with myelofibrosis (MF). The aim of this work was to evaluate the efficacy of lenalidomide in patients with...
3.
Schmidt S, Wolf D, Thaler J, Burgstaller S, Linkesch W, Petzer A, et al.
Wien Klin Wochenschr
. 2010 Oct;
122(19-20):558-66.
PMID: 20936366
The Austrian chronic myeloid leukemia (CML) registry monitors individual disease courses, treatments applied, clinical outcome, and side effects of CML patients on a nationwide basis to provide data on the...
4.
Krauth M, Herndlhofer S, Schmook M, Mitterbauer-Hohendanner G, Schlogl E, Valent P
Haematologica
. 2010 Oct;
96(1):163-6.
PMID: 20934998
Dasatinib is considered an effective drug in imatinib-resistant chronic myeloid leukemia. Although reported to be well-tolerated, severe events such as pleural or pericardial effusion have been reported at 140 mg...
5.
Steurer M, Gastl G, Jedrzejczak W, Pytlik R, Lin W, Schlogl E, et al.
Cancer
. 2004 Oct;
101(10):2239-46.
PMID: 15476273
Background: Although the platelet count does not correlate with the rate of thrombosis, there is evidence that a strict control of the platelet count decreases the incidence of thromboembolic complications...